Patents by Inventor Michael L. Blomquist

Michael L. Blomquist has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11967292
    Abstract: An apparatus comprising a pump configured to deliver insulin, a processor, and a user interface including a color display. Color on the display can be used to bring a user's attention to a change in status of the device or a detected change in status of the patient.
    Type: Grant
    Filed: October 28, 2022
    Date of Patent: April 23, 2024
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Michael L. Blomquist, Timothy B. Bresina, Gail Beth Bynum, Michael D. Welsch
  • Publication number: 20240071594
    Abstract: An apparatus comprising a controller. The controller includes an input/output (I/O) module and a rule module. The I/O module is configured to present a question for a patient when communicatively coupled to a user interface and receive patient information in response to the question via the user interface. The rule module is configured to apply a rule to the patient information and generate a suggested insulin pump setting from application of the rule. Other devices, systems, and methods are disclosed.
    Type: Application
    Filed: November 8, 2023
    Publication date: February 29, 2024
    Inventor: Michael L. Blomquist
  • Patent number: 11848089
    Abstract: An apparatus comprising a controller. The controller includes an input/output (I/O) module and a rule module. The I/O module is configured to present a question for a patient when communicatively coupled to a user interface and receive patient information in response to the question via the user interface. The rule module is configured to apply a rule to the patient information and generate a suggested insulin pump setting from application of the rule. Other devices, systems, and methods are disclosed.
    Type: Grant
    Filed: February 10, 2022
    Date of Patent: December 19, 2023
    Assignee: Tandem Diabetes Care, Inc.
    Inventor: Michael L. Blomquist
  • Publication number: 20230352139
    Abstract: An apparatus comprising a pump, an input configured to receive information related to a user, a user interface, and a controller communicatively coupled to the pump, the input, and the user interface. The controller includes a timing module configured to initiate delivery of a drug in time and to adjust delivery according to the received information. Other devices, systems, and methods are disclosed.
    Type: Application
    Filed: June 6, 2023
    Publication date: November 2, 2023
    Inventors: Michael L. Blomquist, Kevin Kopp, Thomas Alan Savard
  • Publication number: 20230050496
    Abstract: This document discusses, among other things, an apparatus comprising a pump configured to deliver insulin, a processor, and a user interface including a bistable display. A display element of the bistable display is placed in one of two stable orientations upon application of a biasing voltage and stays in the stable orientation when the biasing voltage is removed. The processor includes a display module configured to display a non-blank reversion display screen on the bistable display when no input is received at the user interface after a specified time duration, and to recurrently change the reversion display screen until input is received at the user interface.
    Type: Application
    Filed: October 28, 2022
    Publication date: February 16, 2023
    Inventors: Michael L. Blomquist, Timothy B. Bresina, Gail Beth Bynum, Michael D. Welsch
  • Patent number: 11580918
    Abstract: This document discusses, among other things, an apparatus comprising a pump configured to deliver insulin, a processor, and a user interface including a bistable display. A display element of the bistable display is placed in one of two stable orientations upon application of a biasing voltage and stays in the stable orientation when the biasing voltage is removed. The processor includes a display module configured to display a non-blank reversion display screen on the bistable display when no input is received at the user interface after a specified time duration, and to recurrently change the reversion display screen until input is received at the user interface.
    Type: Grant
    Filed: May 2, 2019
    Date of Patent: February 14, 2023
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Michael L. Blomquist, Timothy B. Bresina, Gail Beth Bynum, Michael D. Welsch
  • Patent number: 11488549
    Abstract: An apparatus comprising a pump configured to deliver insulin, a processor, and a user interface including a color display. Color on the display can be used to bring a user's attention to a change in status of the device or a detected change in status of the patient.
    Type: Grant
    Filed: September 28, 2020
    Date of Patent: November 1, 2022
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Michael L. Blomquist, Timothy B. Bresina, Gail Beth Bynum, Michael D. Welsch
  • Publication number: 20220230726
    Abstract: An apparatus comprising a pump, an input configured to receive information related to a user, a user interface, and a controller communicatively coupled to the pump, the input, and the user interface. The controller includes a timing module configured to initiate delivery of a drug in time and to adjust delivery according to the received information. Other devices, systems, and methods are disclosed.
    Type: Application
    Filed: April 7, 2022
    Publication date: July 21, 2022
    Inventors: Michael L. Blomquist, Kevin Kopp, Thomas Alan Savard
  • Publication number: 20220226566
    Abstract: An apparatus comprising a user interface configured to generate an electrical signal to start a basal insulin rate test when prompted by a user, an input configured to receive sampled blood glucose data of a patient that is obtained during a specified time duration, including a time duration during delivery of insulin according to a specified basal insulin rate pattern, and a controller communicatively coupled to the input and the user interface. The controller includes an insulin calculation module configured for determining at least one of an amount of basal insulin over-delivered and an amount of basal insulin under-delivered during the basal insulin rate test in trying to meet a target blood glucose baseline. Other devices and methods are disclosed.
    Type: Application
    Filed: April 5, 2022
    Publication date: July 21, 2022
    Inventors: Michael L. Blomquist, Thomas Alan Savard
  • Publication number: 20220165386
    Abstract: An apparatus comprising a controller. The controller includes an input/output (I/O) module and a rule module. The I/O module is configured to present a question for a patient when communicatively coupled to a user interface and receive patient information in response to the question via the user interface. The rule module is configured to apply a rule to the patient information and generate a suggested insulin pump setting from application of the rule. Other devices, systems, and methods are disclosed.
    Type: Application
    Filed: February 10, 2022
    Publication date: May 26, 2022
    Inventor: Michael L. Blomquist
  • Patent number: 11302433
    Abstract: An apparatus comprising a pump, an input configured to receive information related to a user, a user interface, and a controller communicatively coupled to the pump, the input, and the user interface. The controller includes a timing module configured to initiate delivery of a drug in time and to adjust delivery according to the received information. Other devices, systems, and methods are disclosed.
    Type: Grant
    Filed: April 25, 2019
    Date of Patent: April 12, 2022
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Michael L. Blomquist, Kevin Kopp, Thomas Alan Savard
  • Patent number: 11291763
    Abstract: An apparatus comprising a user interface configured to generate an electrical signal to start a basal insulin rate test when prompted by a user, an input configured to receive sampled blood glucose data of a patient that is obtained during a specified time duration, including a time duration during delivery of insulin according to a specified basal insulin rate pattern, and a controller communicatively coupled to the input and the user interface. The controller includes an insulin calculation module configured for determining at least one of an amount of basal insulin over-delivered and an amount of basal insulin under-delivered during the basal insulin rate test in trying to meet a target blood glucose baseline. Other devices and methods are disclosed.
    Type: Grant
    Filed: September 15, 2016
    Date of Patent: April 5, 2022
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Michael L. Blomquist, Thomas Alan Savard
  • Publication number: 20220101978
    Abstract: Methods of establishing an insulin delivery rate in a pump and an insulin pump are disclosed. A method includes selecting a set of alerts from one or more sets of alerts. The method also includes initiating a test process based on the set of alerts. The method further includes, upon activation of each alert in the selected set of alerts, prompting a user to input a blood glucose level.
    Type: Application
    Filed: December 13, 2021
    Publication date: March 31, 2022
    Inventor: Michael L. Blomquist
  • Patent number: 11257580
    Abstract: An apparatus comprising a controller. The controller includes an input/output (I/O) module and a rule module. The I/O module is configured to present a question for a patient when communicatively coupled to a user interface and receive patient information in response to the question via the user interface. The rule module is configured to apply a rule to the patient information and generate a suggested insulin pump setting from application of the rule. Other devices, systems, and methods are disclosed.
    Type: Grant
    Filed: March 8, 2021
    Date of Patent: February 22, 2022
    Assignee: Tandem Diabetes Care, Inc.
    Inventor: Michael L. Blomquist
  • Patent number: 11217339
    Abstract: A database of foods can be employed for configuring delivery of a bolus with an insulin pump. A user of the pump selects one or more foods from the database of foods to form a meal from which the user's carbohydrate intake is calculated. The database of foods can include a number of records associated with food entries.
    Type: Grant
    Filed: April 16, 2018
    Date of Patent: January 4, 2022
    Assignee: Tandem Diabetes Care, Inc.
    Inventor: Michael L. Blomquist
  • Publication number: 20210193288
    Abstract: An apparatus comprising a controller. The controller includes an input/output (I/O) module and a rule module. The I/O module is configured to present a question for a patient when communicatively coupled to a user interface and receive patient information in response to the question via the user interface. The rule module is configured to apply a rule to the patient information and generate a suggested insulin pump setting from application of the rule. Other devices, systems, and methods are disclosed.
    Type: Application
    Filed: March 8, 2021
    Publication date: June 24, 2021
    Inventor: Michael L. Blomquist
  • Patent number: 10943687
    Abstract: An apparatus including a controller can determine a rate of change of a blood glucose level of a patient and generate a pump setting based on the rate of change.
    Type: Grant
    Filed: July 10, 2019
    Date of Patent: March 9, 2021
    Assignee: Tandem Diabetes Care, Inc.
    Inventor: Michael L. Blomquist
  • Publication number: 20210012875
    Abstract: This document discusses, among other things, an apparatus comprising a pump configured to deliver insulin, a processor, and a user interface including a bistable display. A display element of the bistable display is placed in one of two stable orientations upon application of a biasing voltage and stays in the stable orientation when the biasing voltage is removed. The processor includes a display module configured to display a non-blank reversion display screen on the bistable display when no input is received at the user interface after a specified time duration, and to recurrently change the reversion display screen until input is received at the user interface.
    Type: Application
    Filed: September 28, 2020
    Publication date: January 14, 2021
    Inventors: Michael L. Blomquist, Timothy B. Bresina, Gail Beth Bynum, Michael D. Welsch
  • Publication number: 20210012876
    Abstract: Methods of insulin delivery and an insulin pump are disclosed.
    Type: Application
    Filed: September 28, 2020
    Publication date: January 14, 2021
    Inventor: Michael L. Blomquist
  • Patent number: 10726100
    Abstract: This document discusses, among other things, an apparatus comprising a pump configured to deliver insulin, a processor, and a user interface including a bistable display. A display element of the bistable display is placed in one of two stable orientations upon application of a biasing voltage and stays in the stable orientation when the biasing voltage is removed. The processor includes a display module configured to display a non-blank reversion display screen on the bistable display when no input is received at the user interface after a specified time duration, and to recurrently change the reversion display screen until input is received at the user interface.
    Type: Grant
    Filed: January 17, 2017
    Date of Patent: July 28, 2020
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Michael L. Blomquist, Timothy B. Bresina, Gail Beth Bynum, Michael D. Welsch